What underdosing means
An ingredient is underdosed when the amount in a product is well below the amount that showed an effect in research, for the same form of the ingredient and the same purpose. The term is not about safety. It describes a gap between what a label implies, that each ingredient contributes, and what the evidence suggests a small dose can do.
Underdosing is easy to hide behind a proprietary blend, where only the total weight is printed. It is visible when every amount is printed, as on the NerveHoney label. That is why this case study is possible at all, and it is a point in the product's favor.
The capsule arithmetic
A standard size 0 capsule holds roughly 400 to 500 mg of a typical herbal powder, depending on density, and size 00 holds more. A two-capsule serving therefore has room for somewhere around 800 to 1,000 mg in total, including fillers.
NerveHoney's five herbs add up to 450 mg, with microcrystalline cellulose and magnesium stearate making up the rest. That is a modest fill. Splitting 450 mg across five herbs means an average of 90 mg each, and the split is uneven:
| Herb | Label mg | Share of actives |
|---|---|---|
| Passionflower | 145 mg | 32% |
| Marshmallow root | 110 mg | 24% |
| Corydalis powder | 100 mg | 22% |
| Prickly pear 20:1 extract | 50 mg | 11% |
| California poppy seed | 45 mg | 10% |
There is nothing wrong with a small total. The question is whether each line is there to work or to be listed.
Line by line against the research
Passionflower, 145 mg. Human trials used drops of extract, a 260 mg tablet and a 500 mg tablet [1] [2] [3]. NerveHoney's amount is lower but in a plausible range. Not clearly underdosed. Marshmallow root, 110 mg. The European monograph describes grams of root, taken as a cold macerate or syrup, for throat irritation [4]. At 110 mg in a capsule, this line is a small fraction of the traditional dose and is aimed at a purpose the research never addressed. Underdosed and off-target. Corydalis powder, 100 mg. Traditional use runs to grams of tuber, and the active alkaloids make up a small share of that. Without an alkaloid figure, the dose cannot be compared, but it is likely low. Probably underdosed. Prickly pear 20:1 extract, 50 mg. No human study exists for this species and purpose, so there is no reference dose [5]. Undetermined, but with no evidence behind it at any dose. California poppy seed, 45 mg. The studied part is the aerial plant, used in combination products [6]; the seed is not studied. Token dose of the wrong part.Why labels end up like this
Several forces push formulas toward many small doses:
- The ingredient list sells. Five named herbs look more thorough than one, and each herb can be given its own benefit on the sales page.
- Capsule space and cost. Fully dosing five herbs would need more capsules a day, which raises cost and lowers adherence.
- Stock formulas. Contract manufacturers offer ready-made blends that many brands relabel. The same NerveHoney amounts appear on at least one other brand.
- The rules allow it. Federal labeling rules require amounts and botanical parts but do not set minimum effective doses [7]. The FDA does not review supplement formulas before sale [8].
None of this is unique to NerveHoney. It is the norm in multi-herb products.
How to spot a token dose
- Find the research dose for the same plant part and purpose. NIH and the European Medicines Agency publish herb monographs; PubMed has the trials.
- Compare like with like: extract with extract, powder with powder, and check extract ratios.
- Be wary of any ingredient under about 50 mg in a herbal formula unless it is a potent standardized extract.
- Notice when a sales page gives a small-dose ingredient a big job, such as protecting nerves or restoring circulation.
- Prefer labels that print every amount, so this check is possible at all.
What a transparent label could add
NerveHoney's label is already better than a blend. Three additions would make it genuinely informative: the plant part on every line, a standardization figure for passionflower and corydalis, and a lot number with a published certificate of analysis. Together they would let a buyer know not just how much plant is in each capsule, but how much of the compounds that matter.
Blends, transparency and what the rules require
Federal labeling rules allow a proprietary blend: a named mixture listed with its total weight, with ingredients in descending order of predominance but no individual amounts [7]. Companies argue that this protects their formulas from copying. In practice it also hides underdosing, because a buyer cannot tell whether the expensive ingredient makes up half the blend or a sprinkle.
NerveHoney does not use a blend. That choice deserves credit, and it is the reason a case study like this can be written at all. A fully disclosed label makes the conversation honest: you can see that passionflower gets 145 mg and poppy seed 45 mg, and decide for yourself what each contributes. When comparing products, a printed amount for every ingredient is one of the strongest single signs of a seller willing to be checked.
Questions readers ask about doses
Is a small dose dangerous? Usually not; underdosing is mainly a value problem. The exception is an ingredient with a safety signal, such as corydalis, where the dose of active compounds is unknown in either direction. Why not just take more capsules? Doubling the serving doubles every herb, including the sedative ones, and the label does not support it. If one ingredient is what you want, a single-ingredient product at a studied dose is the cleaner choice. Are extracts always stronger than powders? Per milligram, usually, but only a stated ratio or standardization tells you by how much. Does a long ingredient list mean a better formula? Often the reverse. Fewer ingredients at meaningful doses beat many at token amounts.The bottom line
In NerveHoney, one ingredient is plausibly dosed, one is probably underdosed with a safety caveat, and three are token amounts. That leaves the product resting on passionflower. Knowing this lets you set your expectations, and compare NerveHoney with simpler, cheaper options. Our guide to reading a supplement label shows how to run this check on any product.
Want the whole label in one place?
Six bottles cost $294 with free U.S. shipping ($1.63 a day); two bottles cost $167.99 with shipping. The 60-day refund clock starts on the order date.
Sources
- Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363-367. pubmed.ncbi.nlm.nih.gov/11679026/
- Dantas LP, de Oliveira-Ribeiro A, de Almeida-Souza LM, Groppo FC. Effects of Passiflora incarnata and midazolam for control of anxiety in patients undergoing dental extraction. Med Oral Patol Oral Cir Bucal. 2017;22(1):e95-e101. pubmed.ncbi.nlm.nih.gov/27918731/
- Movafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study. Anesth Analg. 2008;106(6):1728-1732. pubmed.ncbi.nlm.nih.gov/18499602/
- European Medicines Agency, Committee on Herbal Medicinal Products. Althaeae radix (marshmallow root): herbal medicine overview and monograph. www.ema.europa.eu/en/medicines/herbal/althaeae-radix
- Valero-Galván J, González-Fernández R, Sigala-Hernández A, et al. Sensory attributes, physicochemical and antioxidant characteristics, and protein profile of wild prickly pear fruits (O. macrocentra, O. phaeacantha, O. engelmannii) and commercial prickly pear fruits (O. ficus-indica). Food Res Int. 2021;140:109909. pubmed.ncbi.nlm.nih.gov/33648207/
- Hanus M, Lafon J, Mathieu M. Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Curr Med Res Opin. 2004;20(1):63-71. pubmed.ncbi.nlm.nih.gov/14741074/
- Electronic Code of Federal Regulations. 21 CFR 101.36: Nutrition labeling of dietary supplements. www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-C/section-101.36
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements